We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Boot Barn
BOOT
$4.58B
| $142K | ﹤0.01% |
14,343
+527
| +4% | +$5.7K |
|
2727
Dawson Geophysical
DWSN
$130M
| $142K | ﹤0.01% |
26,780
+988
| +4% | +$6.82K |
|
|
AMBR
2728
DELISTED
Amber Road Inc
AMBR
| $142K | ﹤0.01% |
18,370
+733
| +4% | +$6.06K |
|
2729
Build-A-Bear
BBW
$445M
| $140K | ﹤0.01% |
15,844
+637
| +4% | +$6.78K |
|
2730
Fortress Biotech
FBIO
$111M
| $140K | ﹤0.01% |
2,518
+715
| +40% | +$32K |
|
|
ATHX
2731
DELISTED
Athersys, Inc. Common Stock
ATHX
| $140K | ﹤0.01% |
3,281
-20
| -0.6% | -$639 |
|
|
NVIV
2732
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
| $140K | ﹤0.01% |
2
| – | – |
|
|
GUID
2733
DELISTED
Guidance Software, Inc.
GUID
| $140K | ﹤0.01% |
23,693
+1,058
| +5% | +$7.22K |
|
|
SRNE
2734
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $137K | ﹤0.01% |
34,686
+2,686
| +8% | +$13.5K |
|
|
IMH
2735
DELISTED
Impac Mortgage Holdings Inc.
IMH
| $136K | ﹤0.01% |
10,938
+380
| +4% | +$5.17K |
|
2736
Arrowhead Research
ARWR
$12.1B
| $135K | ﹤0.01% |
73,128
+18,730
| +34% | +$37.1K |
|
|
CTLP
2737
DELISTED
Cantaloupe
CTLP
| $134K | ﹤0.01% |
31,467
+1,676
| +6% | +$7.1K |
|
2738
Sportsman's Warehouse
SPWH
$44.9M
| $134K | ﹤0.01% |
27,955
+1,205
| +5% | +$7.5K |
|
2739
VirnetX Holding Corp
VHC
$53.8M
| $134K | ﹤0.01% |
2,912
+113
| +4% | +$5.19K |
|
|
AAC
2740
DELISTED
AAC Holdings
AAC
| $134K | ﹤0.01% |
+15,679
| New | +$128K |
|
|
ISEE
2741
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $133K | ﹤0.01% |
36,440
+1,277
| +4% | +$5.4K |
|
|
EGLT
2742
DELISTED
Egalet Corporation
EGLT
| $132K | ﹤0.01% |
25,939
+939
| +4% | +$4.89K |
|
|
XONE
2743
DELISTED
The ExOne Company
XONE
| $131K | ﹤0.01% |
12,901
+510
| +4% | +$5.14K |
|
|
JMBA
2744
DELISTED
Jamba, Inc.
JMBA
| $131K | ﹤0.01% |
14,525
+598
| +4% | +$5.75K |
|
2745
Larimar Therapeutics
LRMR
$377M
| $130K | ﹤0.01% |
2,325
+551
| +31% | +$27.4K |
|
|
RSYS
2746
DELISTED
Radisys Corp
RSYS
| $130K | ﹤0.01% |
32,550
+1,666
| +5% | +$6.88K |
|
|
NEOS
2747
DELISTED
Neos Therapeutics, Inc
NEOS
| $129K | ﹤0.01% |
17,968
+4,985
| +38% | +$30.9K |
|
2748
Century Casinos
CNTY
$32.9M
| $127K | ﹤0.01% |
16,789
+925
| +6% | +$6.7K |
|
|
NWHM
2749
DELISTED
THE NEW HOME COMPANY INC.
NWHM
| $127K | ﹤0.01% |
12,155
+598
| +5% | +$6.45K |
|
2750
Jakks Pacific
JAKK
$303M
| $126K | ﹤0.01% |
2,289
+62
| +3% | +$3.31K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.